Kevin Koch - 12 Aug 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
President and CEO, Director
Signature
/s/John R. Moore Attorney-in-Fact for Kevin Koch
Issuer symbol
EWTX
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 16:14:40 UTC
Previous filing
03 May 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +431,250 $0.000000 431,250 12 Aug 2024 Common Stock 431,250 $17.05 Direct F1
transaction EWTX Restricted Stock Units Award $0 +71,875 $0.000000 71,875 12 Aug 2024 Common Stock 71,875 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date.
F2 Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024.